Author

Beverly A. Teicher

National Institutes of HealthORCID 0000-0003-1535-7304Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Assay:bulk RNA-seq· 3 Research Focus:drug response / drug discovery· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Anish ThomasiD· 2 shared James H. DoroshowiD· 2 shared Melinda G. HollingsheadiD· 2 shared Naoko TakebeiD· 2 shared Nathan P. CoussensiD· 2 shared Thomas E. SilversiD· 2 shared Thomas Steven DexheimeriD· 2 shared Ajit Kumar SharmaiD· 1 shared

Activity by Year

2019-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anish ThomasORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer BiologyCancer Research CommunicationsPeer-reviewedSep 17, 2025

Combinations of RAS pathway inhibitors with targeted agents are active in spheroids of patient-derived cells with oncogenic KRAS variants from multiple cancer types

Zahra Davoudi, Thomas Steven Dexheimer, Nathan P. Coussens…·Beverly A. Teicher

This study screens combinations of RAS pathway inhibitors with targeted agents in patient-derived spheroids with KRAS variants, identifying effective combinations that reduce viability.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 29, 2025

Lamin A/C Deficiency Drives Genomic Instability and Poor Survival in Small-Cell Lung Cancer through Increased R-loop Accumulation

Christopher William Schultz, Sourav Taru Saha, Anjali Dhall…·Anish Thomas

This study shows that LMNA deficiency in SCLC increases R-loop accumulation, leading to genomic instability and poor patient survival.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologySLAS DISCOVERYPeer-reviewedApr 9, 2025

Drug combinations with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids

Nathan P. Coussens, Thomas Steven Dexheimer, Thomas E. Silvers…·Beverly A. Teicher

The paper evaluates combinations of apoptosis pathway inhibitors with other agents in multi-cell type tumor spheroids to identify effective therapeutic strategies.

6 citations

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 11, 2019

Neuroendocrine negative SCLC is mostly RB1 WT and may be sensitive to CDK4/6 inhibition

Dmitriy Sonkin, Suleyman Vural, Anish Thomas, Beverly A. Teicher

The paper identifies RB1 WT SCLC cell lines and finds some are sensitive to CDK4/6 inhibition.

DOI 10.1101/516351

humanbulk RNA-seq

𝕏 PostBluesky